- Home
- MAMA vs CDTX Comparison
MAMA vs CDTX Comparison
Compare MAMA & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- CDTX
- Stock Information
- Founded
- MAMA 2010
- CDTX 2012
- Country
- MAMA United States
- CDTX United States
- Employees
- MAMA N/A
- CDTX N/A
- Industry
- MAMA Specialty Foods
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- CDTX Health Care
- Exchange
- MAMA Nasdaq
- CDTX Nasdaq
- Market Cap
- MAMA 290.7M
- CDTX 242.5M
- IPO Year
- MAMA N/A
- CDTX 2015
- Fundamental
- Price
- MAMA $7.67
- CDTX $27.30
- Analyst Decision
- MAMA Strong Buy
- CDTX Strong Buy
- Analyst Count
- MAMA 3
- CDTX 6
- Target Price
- MAMA $10.67
- CDTX $32.20
- AVG Volume (30 Days)
- MAMA 473.3K
- CDTX 80.0K
- Earning Date
- MAMA 12-16-2024
- CDTX 11-07-2024
- Dividend Yield
- MAMA N/A
- CDTX N/A
- EPS Growth
- MAMA N/A
- CDTX N/A
- EPS
- MAMA 0.08
- CDTX N/A
- Revenue
- MAMA $116,468,000.00
- CDTX $44,653,000.00
- Revenue This Year
- MAMA $18.91
- CDTX N/A
- Revenue Next Year
- MAMA $12.69
- CDTX N/A
- P/E Ratio
- MAMA $91.21
- CDTX N/A
- Revenue Growth
- MAMA 17.20
- CDTX 44.48
- 52 Week Low
- MAMA $4.17
- CDTX $10.00
- 52 Week High
- MAMA $9.98
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- MAMA 39.03
- CDTX 73.84
- Support Level
- MAMA $7.55
- CDTX $19.24
- Resistance Level
- MAMA $9.83
- CDTX $24.31
- Average True Range (ATR)
- MAMA 0.46
- CDTX 2.01
- MACD
- MAMA -0.11
- CDTX 0.20
- Stochastic Oscillator
- MAMA 17.27
- CDTX 87.80
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.